Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
That number is expected to grow even more in the coming years, as the exam serves as a noninvasive alternative to colonoscopy, while also providing more accurate results than stool tests.
Despite kicking their initial habit, these individuals remain at risk of developing lung cancer due to their history of smoking cigarettes, current use of e-cigarettes, or both, experts caution.
The WISEWOMAN program proved to be a useful intervention to screen low-income, uninsured women and offer them risk reduction counseling to improve blood pressure, diet and physical activity.
CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology.